Center for Bio/Molecular Science and Engineering, Naval Research Laboratory , 4555 Overlook Avenue Southwest, Washington, D.C., 20375, United States.
ACS Nano. 2014 Jul 22;8(7):6986-97. doi: 10.1021/nn501816z. Epub 2014 Jul 10.
A continuing goal of nanoparticle (NP)-mediated drug delivery (NMDD) is the simultaneous improvement of drug efficacy coupled with tracking of the intracellular fate of the nanoparticle delivery vehicle and its drug cargo. Here, we present a robust multifunctional liquid crystal NP (LCNP)-based delivery system that affords facile intracellular fate tracking coupled with the efficient delivery and modulation of the anticancer therapeutic doxorubicin (Dox), employed here as a model drug cargo. The LCNPs consist of (1) a liquid crystal cross-linking agent, (2) a homologue of the organic chromophore perylene, and (3) a polymerizable surfactant containing a carboxylate headgroup. The NP core provides an environment to both incorporate fluorescent dye for spectrally tuned particle tracking and encapsulation of amphiphilic and/or hydrophobic agents for intracellular delivery. The carboxylate head groups enable conjugation to biologicals to facilitate the cellular uptake of the particles. Upon functionalization of the NPs with transferrin, we show the ability to differentially label the recycling endocytic pathway in HEK 293T/17 cells in a time-resolved manner with minimal cytotoxicity and with superior dye photostability compared to traditional organic fluorophores. Further, when passively loaded with Dox, the NPs mediate the rapid uptake and subsequent sustained release of Dox from within endocytic vesicles. We demonstrate the ability of the LCNPs to simultaneously serve as both an efficient delivery vehicle for Dox as well as a modulator of the drug's cytotoxicity. Specifically, the delivery of Dox as a LCNP conjugate results in a ∼40-fold improvement in its IC50 compared to free Dox in solution. Cumulatively, our results demonstrate the utility of the LCNPs as an effective nanomaterial for simultaneous cellular imaging, tracking, and delivery of drug cargos.
纳米粒子(NP)介导的药物输送(NMDD)的持续目标是同时提高药物疗效,同时跟踪纳米颗粒输送载体和其药物货物的细胞内命运。在这里,我们提出了一种稳健的多功能液晶 NP(LCNP)基输送系统,该系统易于进行细胞内命运跟踪,同时有效地输送和调节抗癌治疗药物阿霉素(Dox),这里用作模型药物货物。LCNP 由(1)液晶交联剂,(2)对苯二甲酸二酯的同系物和(3)含有羧酸盐头基的可聚合表面活性剂组成。NP 核提供了一个环境,既可以掺入荧光染料以进行光谱调谐的粒子跟踪,又可以包封两亲性和/或疏水性试剂以进行细胞内输送。羧酸盐头基能够与生物分子缀合,以促进粒子的细胞摄取。当 NPs 用转铁蛋白功能化时,我们以时间分辨的方式显示出能够以最小的细胞毒性和与传统有机荧光团相比具有优越的染料光稳定性来区分标记 HEK 293T/17 细胞中的再循环内吞途径的能力。此外,当被动加载 Dox 时,NP 介导 Dox 从内吞小泡中快速摄取和随后的持续释放。我们证明了 LCNP 能够同时作为 Dox 的有效输送载体以及药物细胞毒性的调节剂。具体而言,与游离 Dox 相比,作为 LCNP 缀合物输送 Dox 可使其 IC50 提高约 40 倍。总之,我们的结果表明,LCNP 作为一种有效的纳米材料,可用于同时进行细胞成像,跟踪和药物货物的输送。